Astera Labs, Inc. (NASDAQ:ALAB) Director Sells $837,426.38 in Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) Director Stefan A. Dyckerhoff sold 7,814 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $107.17, for a total transaction of $837,426.38. Following the completion of the transaction, the director now directly owns 121,803 shares of the company’s stock, valued at $13,053,627.51. This represents a 6.03 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Astera Labs Stock Performance

Astera Labs stock traded down $1.83 during midday trading on Tuesday, reaching $105.48. The stock had a trading volume of 4,339,811 shares, compared to its average volume of 3,179,274. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $113.85. The company has a fifty day moving average of $70.87 and a 200 day moving average of $60.05.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm had revenue of $113.10 million for the quarter, compared to the consensus estimate of $97.50 million. Astera Labs’s revenue was up 47.1% on a year-over-year basis. Research analysts forecast that Astera Labs, Inc. will post -0.45 EPS for the current year.

Institutional Trading of Astera Labs

A number of large investors have recently made changes to their positions in the stock. Strategic Blueprint LLC increased its stake in Astera Labs by 3.6% in the 3rd quarter. Strategic Blueprint LLC now owns 5,684 shares of the company’s stock worth $298,000 after buying an additional 195 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Astera Labs by 5.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock worth $277,000 after acquiring an additional 284 shares during the period. Hollencrest Capital Management purchased a new position in shares of Astera Labs during the third quarter worth approximately $26,000. Venturi Wealth Management LLC raised its stake in shares of Astera Labs by 26.3% during the third quarter. Venturi Wealth Management LLC now owns 2,400 shares of the company’s stock valued at $126,000 after acquiring an additional 500 shares in the last quarter. Finally, US Bancorp DE purchased a new stake in shares of Astera Labs in the third quarter valued at approximately $46,000.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $65.00 price objective on shares of Astera Labs in a research note on Wednesday, October 9th. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Craig Hallum boosted their target price on shares of Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Morgan Stanley raised their target price on shares of Astera Labs from $74.00 to $94.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Evercore ISI reduced their price target on shares of Astera Labs from $98.00 to $80.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $94.67.

Read Our Latest Research Report on Astera Labs

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.